3 min read
Mass Spectrometry for Complex Biotherapeutics: Q&A with KBI's Mass Spec Team
CDMOs are becoming increasingly important for developers to reach efficient vaccine and complex biotherapeutic development for their advanced...
Presentation | Host Cell Protein Analysis by Mass Spectrometry
Michael J Nold, Ph.D., Mass Spectrometry Core Facility, KBI Biopharma
__
Originally presented at the 2018 Sciex Users Meeting by Michael J Nold, Ph.D., Mass Spectrometry Core Facility, KBI Biopharma.
3 min read
CDMOs are becoming increasingly important for developers to reach efficient vaccine and complex biotherapeutic development for their advanced...
2 min read
Bispecific antibodies (bsAbs) are rapidly emerging as a significant class of biotherapeutics. Unlike monoclonal antibodies (mAbs), which have a...
At KBI Biopharma, our PUREplatform™ is everything you need to make a protein. Catered to your needs, our service package contains plasmids, strains,...